165 related articles for article (PubMed ID: 3102694)
1. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain.
Cheeseman AJ; Clark JB
J Neurochem; 1987 Apr; 48(4):1209-14. PubMed ID: 3102694
[TBL] [Abstract][Full Text] [Related]
2. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
Kinemuchi H; Arai Y; Toyoshima Y
Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
[TBL] [Abstract][Full Text] [Related]
3. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
Vyas I; Heikkila RE; Nicklas WJ
J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
Takamidoh H; Naoi M; Nagatsu T
Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Hirata Y; Nagatsu T
Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
Kass GE; Wright JM; Nicotera P; Orrenius S
Arch Biochem Biophys; 1988 Feb; 260(2):789-97. PubMed ID: 2963592
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
Mizuno Y; Sone N; Saitoh T
J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
[TBL] [Abstract][Full Text] [Related]
9. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rat brain monoamine oxidase by some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion.
Arai Y; Kinemuchi H; Hamamichi N; Satoh N; Tadano T; Kisara K
Neurosci Lett; 1986 May; 66(1):43-8. PubMed ID: 3487053
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent inhibition of rat brain monoamine oxidase by an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine.
Arai Y; Hamamichi N; Kinemuchi H
Neurosci Lett; 1986 Oct; 70(2):255-60. PubMed ID: 3490636
[TBL] [Abstract][Full Text] [Related]
12. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
Nakamura S; Vincent SR
Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052
[TBL] [Abstract][Full Text] [Related]
13. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Salach JI; Crabtree D
Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
[TBL] [Abstract][Full Text] [Related]
14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes.
Di Monte D; Jewell SA; Ekström G; Sandy MS; Smith MT
Biochem Biophys Res Commun; 1986 May; 137(1):310-5. PubMed ID: 3487319
[TBL] [Abstract][Full Text] [Related]
15. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
Kindt MV; Heikkila RE
Life Sci; 1986 Apr; 38(16):1459-62. PubMed ID: 3084895
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo.
Mizuno Y; Suzuki K; Sone N; Saitoh T
Neurosci Lett; 1988 Sep; 91(3):349-53. PubMed ID: 3141846
[TBL] [Abstract][Full Text] [Related]
17. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
J Pharmacol Exp Ther; 1986 Aug; 238(2):648-52. PubMed ID: 3488394
[TBL] [Abstract][Full Text] [Related]
18. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
[TBL] [Abstract][Full Text] [Related]
19. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
[TBL] [Abstract][Full Text] [Related]
20. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.
Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K
Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
